newsfilter
← Latest News
Business Wire·

IBRX INVESTOR REMINDER: ImmunityBio, Inc. Investors Have Until May 26, 2026 To Seek Lead Plaintiff Role

If you have suffered a loss on your ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ:IBRX) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the